Serotonin 5‑hydroxytryptamine receptor 1A (5-HT1A receptor)

The **Serotonin 5‑hydroxytryptamine receptor 1A** (5-HT1A receptor) is a member of the G protein-coupled receptor family and plays a critical role in regulating mood, emotion, and various central nervous system processes[1][3][4][5]. It is widely expressed in the brain, particularly in the frontal cortex, hippocampus, amygdala, and raphe nuclei, as well as in some peripheral organs[1][7]. The receptor functions both as a presynaptic autoreceptor (inhibiting serotonin release via negative feedback) and as a postsynaptic receptor (modulating neuronal activity), with divergent roles depending on localization[2][3]. It is a well-validated therapeutic target for depression, anxiety, and some neurodegenerative and behavioral disorders, with both direct agonists and indirect modulators (e.g., SSRIs) exerting clinical benefit through effects at this receptor. Newer strategies aim to develop ligands with improved selectivity and signaling bias to reduce side effects and enhance efficacy[3][4][5][8].

Other names

Serotonin 1A receptor5-HT1A receptor5-hydroxytryptamine receptor 1AHTR1A

Agonism (full or partial) at the 5-HT1A receptor (anxiolytic, antidepressant, antipsychotic effects); Antagonism at the 5-HT1A receptor (potential cognitive enhancement, appetite regulation); Modulation of serotonergic neurotransmission (autoinhibitory regulation and postsynaptic activation); Biased agonism (selective pathway activation for improved side effect profiles)